Mast cell leukemia not having achieved remission is a rare hematological malignancy characterized by the proliferation of mast cells in the bone marrow and peripheral blood. This condition is clinically significant due to its aggressive nature and potential for severe symptoms, including anaphylaxis and organ dysfunction. Accurate coding with ICD-10 Code C94.30 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C94.30 represents Mast cell leukemia not having achieved remission, indicating a persistent and uncontrolled proliferation of mast cells. This code is used when documenting cases where the disease has not responded to treatment, highlighting the need for ongoing management and intervention. It is crucial for accurate clinical documentation and billing, particularly in cases requiring specialized care.
Mast cell leukemia not having achieved remission is caused by genetic mutations leading to the uncontrolled growth of mast cells. The condition can progress rapidly, resulting in severe symptoms and complications that necessitate immediate medical attention. Early diagnosis and appropriate treatment are critical to managing this aggressive disease.
ICD-10 Code C94.30 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and guiding clinical decision-making.
In SOAP notes, ICD-10 Code C94.30 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of mast cell leukemia not having achieved remission. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Mast cell leukemia not having achieved remission requires urgent medical intervention, often necessitating hospitalization for intensive treatment. Management strategies focus on controlling symptoms and preventing complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C94.30 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count (CBC) with differential. |
| 88305 | Pathology examination of bone marrow biopsy. |
| 96413 | Chemotherapy administration, intravenous. |
| 99223 | Initial hospital care, typically 70 minutes. |
Common Questions About Using ICD-10 Code C94.30 for Mast cell leukemia not having achieved remission
What are the common symptoms of mast cell leukemia?
Common symptoms include flushing, itching, abdominal pain, and anaphylactic reactions. Patients may also experience fatigue and weakness due to the disease's impact on overall health.
How is mast cell leukemia diagnosed?
Diagnosis typically involves blood tests showing elevated tryptase levels, bone marrow biopsy revealing mast cell proliferation, and clinical assessment of symptoms.
What treatments are available for mast cell leukemia?
Treatment options include antihistamines, corticosteroids, chemotherapy, and targeted therapies. Management focuses on controlling symptoms and preventing complications.
Is mast cell leukemia a curable condition?
Mast cell leukemia is often challenging to treat and may not be curable. However, effective management can help control symptoms and improve quality of life.
Clinical Notes
SOAP notes
DAP notes
AI medical notes